Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
541 studies found for:    Open Studies | "Pancreatic Neoplasms"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Pancreatic Neoplasms" (541 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Recruiting Exceptional Responders With Pancreatic Cancer to Chemotherapy
Condition: Pancreatic Neoplasms
Intervention: Drug: Standard of care chemotherapy
2 Recruiting Institut Paoli-Calmettes Pancreatic Neoplasms Database
Condition: Pancreatic Neoplasms
Intervention: Other: Data collection
3 Recruiting Fluorouracil and Oxaliplatin as First-line for Advanced Pancreatic Cancer
Condition: Pancreatic Neoplasms
Intervention: Drug: mFLOX
4 Recruiting Combination Therapy With NC-6004 and Gemcitabine Versus Gemcitabine Alone in Pancreatic Cancer
Condition: Pancreatic Neoplasms
Interventions: Drug: NC-6004;   Drug: Gemcitabine
5 Not yet recruiting Trial of Neoadjuvant Short Course IMRT Followed by Surgery and IORT for Resectable Pancreatic Cancer
Condition: Pancreatic Neoplasms
Interventions: Radiation: neoadjuvant short course IMRT;   Radiation: IORT
6 Recruiting Efficacy and Feasibility of Combining FOLFIRINOX and Stereotactic Radiotherapy for Patients With Irresectable Locally Advanced Pancreatic Cancer.
Condition: Pancreatic Neoplasms
Intervention: Radiation: stereotactic radiotherapy
7 Recruiting Phase 2 Nab® -Paclitaxel (Abraxane®) Plus Gemcitabine in Subjects With Locally Advanced Pancreatic Cancer (LAPC)
Condition: Pancreatic Neoplasms
Interventions: Drug: nab-Paclitaxel;   Drug: Gemcitabine;   Drug: Chemoradiation;   Drug: Capecitabine;   Procedure: Surgery
8 Recruiting Analgesia and Pancreatic Cancer Surgery
Condition: Pancreatic Neoplasms
Interventions: Procedure: Epidural patient controlled analgesia;   Drug: Intravenous patient controlled analgesia
9 Recruiting A Study to Assess Clinical an Patient Reported Outcomes With Nab-paclitaxel in Combination With Gemcitabine in Route Clinical Practice Treating Pancreatic Cancer
Condition: Pancreatic Neoplasms
Intervention:
10 Recruiting Gemcitabine, Ascorbate, Radiation Therapy for Pancreatic Cancer, Phase I
Condition: Pancreatic Neoplasms
Interventions: Drug: Ascorbate;   Drug: Gemcitabine;   Radiation: Radiation therapy
11 Recruiting Apatinib as Second-line Treatment of Advanced Pancreatic Cancer
Condition: Pancreatic Neoplasms
Intervention: Drug: Apatinib
12 Recruiting SBRT Pre-operatively for Borderline Resectable Pancreatic Cancer
Condition: Pancreatic Neoplasms
Intervention: Radiation: 5-fraction stereotactic body radiation therapy
13 Recruiting Observational Study of Quality of Live in Patients With Metastatic Pancreatic Cancer
Condition: Pancreatic Neoplasms
Intervention: Other: N/A (non-interventional study)
14 Recruiting Study of CG200745 PPA in Combination With Gemcitabine and Erlotinib for Advanced Pancreatic Cancer
Condition: Pancreatic Neoplasms
Interventions: Drug: CG200745 PPA;   Drug: Gemcitabine;   Drug: Erlotinib
15 Recruiting Prognostic and Predictive Biomarkers of Therapeutic Response in Pancreatic Tumors
Condition: Pancreatic Tumor
Intervention: Procedure: suspected pancreatic tumor
16 Recruiting A Study of Vantictumab (OMP-18R5) in Combination With Nab-Paclitaxel and Gemcitabine in Previously Untreated Stage IV Pancreatic Cancer
Conditions: Pancreatic Cancer;   Stage IV Pancreatic Cancer
Interventions: Drug: Vantictumab;   Drug: Nab-Paclitaxel;   Drug: Gemcitabine
17 Recruiting Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer
Conditions: Pancreatic Cancer;   Stage IV Pancreatic Cancer
Intervention: Drug: OMP-54F28, Nab-Paclitaxel and Gemcitabine
18 Recruiting Systemic Therapy and Chemoradiation in Advanced Localised Pancreatic Cancer - 2
Condition: Pancreatic Neoplasms (Locally Advanced Non-metastatic)
Interventions: Drug: nab-paclitaxel;   Radiation: 60Gy in 30#;   Radiation: 50.4Gy in 28#;   Drug: Nelfinavir;   Drug: Capecitabine;   Drug: Gemcitabine
19 Recruiting Evaluation of Prognosis With Integrated MRI/PET in Patients With Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Device: The imaging biomarkers determined by MR-PET
20 Recruiting Study of Stereotactic Body Radiation Therapy in Patients With Intact Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Radiation: Stereotactic Radiation

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.